Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV L-Citrulline for ALI Prevention in Pediatric Heart Surgery
NCT05253209Phase 3Terminated
- Sponsor
- Asklepion Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of citrulline in acute lung injury (ALI), sponsored by Asklepion Pharmaceuticals. Started Jun 2022; status: terminated.
02
Drugs
citrulline
03
Conditions
acute lung injury (ALI)
Beyond the preview
Go deeper on NCT05253209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05253209.